ProShares Ultra Nasdaq Biotechnolog... (BIB)
|52 Week Range||38.42-67.31|
|1y Target Est||-|
|DCF Unlevered||BIB DCF ->|
|DCF Levered||BIB LDCF ->|
|Debt / Equity||-|
Upgrades & Downgrades
Latest BIB news
The 7 Best ETFs to Buy to Cover 2023's Biggest Investing Opportunities
20 December 2022
These are some of the best ETFs to buy and hold heading into New Year 2023. Rather than being completely tied to the ebb and flow of single-stock ideas, you can gain access to a broad number of simila...
The 7 Hottest Biotech Stocks to Own in 2023 and Beyond
18 December 2022
Some of the hottest biotech stocks are safe and recession-proof. After all, we can't stop people from aging – at least, not yet.
Why Now Could Be The Time To Consider Neuroscience Investments
27 August 2022
Recognition that aging populations will give rise to new healthcare needs and heightened awareness of mental health issues are bringing renewed focus to neurological health. Recent advances in genomic...
Top Performing Leveraged/Inverse ETFs: 08/07/2022
9 August 2022
Top Performing Levered/Inverse ETFs Last Week These were last week's top-performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
Cap-Weighting Crucial When Indexing Biotech
25 January 2022
The biotechnology industry is a bifurcated space. In one corner, you have nascent, small-cap companies that don't yet have steady revenue streams because their new drug or treatment is still in develo...
How to Invest in Biotech in 2022
15 December 2021
It's been a hard year for a lot of the biotech industry, with many hedge funds ending the year with significant losses, but there have been a number of shining stars that are expected to continue to o...
Take a Look at the Top-Performing Biotech ETFs YTD
2 October 2021
The pandemic has triggered a race to introduce vaccines and treatment options, opening up investment opportunities in the biotech sector.
Tap the Red Hot Biotech Sector With These 2 Leveraged ETFs
26 August 2021
Investors could easily tap the bullish trend by considering a near-term long on the biotech sector.
Pfizer-BioNTech COVID-19 Vaccine Garners Full FDA Approval
24 August 2021
The FDA has officially given full approval to Pfizer and BioNTech for their COVID-19 vaccine, potentially making way for more approvals and more vaccine mandates, reports CNBC. It is a move that offic...
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
Stock Value >
Financial Summary > Financial Statements > Financial Quarter Statements > Ratios Analysis > Dupont Analysis > Free Cash Flow > Operating Data > Balance Sheet Data >